Patent · US Active

Chemical compounds

US8114885B2 · kind B2 · utility

19Cited by
8References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 30, 2007
Grant dateFeb 14, 2012
Priority date
Expiry dateJul 30, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.